Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02873949Completed
Open-label trial (2 arms), sponsored by CHRU de Nancy - Hôpital Central. Primary endpoint: Average concentration of soluble TREM-1 and TREM-2 in crevicular fluid at Day 0. Started Apr 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02873949.